TLSA
Tiziana Life Sciences Ltd
NASDAQ: TLSA · HEALTHCARE · BIOTECHNOLOGY
$1.28
+1.59% today
Updated 2026-04-30
Market cap
$159.06M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$1 – $3
Volume
0.1M
Tiziana Life Sciences Ltd (TLSA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-232.30%
ROA
-83.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $116000.00 | $-2.14M | 65.52% | -1,907.76% | -1,845.69% |
| 2006 | $405000.00 | $-2.18M | 48.40% | -564.44% | -537.28% |
| 2007 | $64000.00 | $-2.42M | 62.50% | -3,982.81% | -3,776.56% |
| 2008 | $92000.00 | $-1.43M | 78.26% | -1,675.00% | -1,553.26% |
| 2009 | $56000.00 | $-730000.00 | 80.36% | -1,346.43% | -1,303.57% |
| 2010 | — | $-4.68M | — | — | — |
| 2011 | $-127313.00 | $-1.21M | 100.00% | 352.44% | 948.78% |
| 2012 | — | $-848000.00 | — | — | — |
| 2013 | $3000.00 | $-280000.00 | 100.00% | -9,533.33% | -9,333.33% |
| 2014 | $0.00 | $-3.51M | — | — | — |
| 2015 | $0.00 | $-12.79M | — | — | — |
| 2016 | $0.00 | $-7.21M | — | — | — |
| 2017 | $0.00 | $-6.77M | — | — | — |
| 2018 | $0.00 | $-6.30M | — | — | — |
| 2019 | $0.00 | $-7.31M | — | — | — |
| 2020 | $0.00 | $-26.13M | — | — | — |
| 2021 | $0.00 | $-23.42M | — | — | — |
| 2022 | $0.00 | $-15.40M | — | — | — |
| 2023 | $0.00 | $-17.69M | — | — | — |
| 2024 | $0.00 | $-11.86M | — | — | — |